Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides

MLA

Kazuhiko Yamasaki, et al. “Development of an Orally-Administrable Tumor Vasculature-Targeting Therapeutic Using Annexin A1-Binding D-Peptides.” PLoS ONE, vol. 16, no. 1, Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ce7b87d02c619ae17d15d163eb32613e&authtype=sso&custid=ns315887.

APA

Kazuhiko Yamasaki, Takashi Yaegashi, Michiko N. Fukuda, Hideaki Mabashi-Asazuma, Itsuko Kimura-Takagi, Motohiro Nonaka, Masato Nagaoka, Toshio Sasai, Chizuko Nishizawa-Harada, Chun-Teng Huang, Yoichi Suwa, Tomoya O. Akama, & Donald L. Jarvis. (2021). Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides. PLoS ONE, 16(1).

Chicago

Kazuhiko Yamasaki, Takashi Yaegashi, Michiko N. Fukuda, Hideaki Mabashi-Asazuma, Itsuko Kimura-Takagi, Motohiro Nonaka, Masato Nagaoka, et al. 2021. “Development of an Orally-Administrable Tumor Vasculature-Targeting Therapeutic Using Annexin A1-Binding D-Peptides.” PLoS ONE 16 (1). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....ce7b87d02c619ae17d15d163eb32613e&authtype=sso&custid=ns315887.